CERO – cero therapeutics holdings, inc. (US:NASDAQ)

News

CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial
CERo Therapeutics Doses Second Patient in Cohort 2 of Phase 1 CER-1236 Trial [Yahoo! Finance]
CERo Therapeutics Doses Second Patient in Cohort 2 of Phase 1 CER-1236 Trial
CERo Therapeutics Provides Shareholder Update [Yahoo! Finance]
CERo Therapeutics Provides Shareholder Update
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com